Primary central nervous system lymphomas in immunocompetent individuals: Histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expression

Leukemia and Lymphoma

Volumn 30, Issue 1-2, 1998, Pages 131-142

  Krogh Jensen, Morten ^a,c   Johansen, Preben ^a,b   D'Amore, Francesco ^d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d NONE

Author keywords

Epstein Barr virus genome; Lymphoma; Non Hodgkin's; Primary central nervous system lymphoma; Proliferation index; Protein bcl 2; Protein p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA; PRIORITY JOURNAL; RNA HYBRIDIZATION; VIRUS GENOME;

EID: 0031817939     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050936     Document Type: Article

References (44)

1. Ferreri, A. J. M., Reni, M. and Villa, E. (1995). Primary central nervous system lymphomas in immunocompetent patients. Cancer Treat. Rev., 21, 415-446.
2. Jellinger, K. A. and Paulus, W. (1992). Primary central nervous system lymphomas - an update. J. Cancer Res. Clin. Oncol., 119, 7-27.
3. Ling, S. M., Ruach, M. III, Larson, D. A. and Wara, W. M. (1994). Radiotherapy of primary central nervous system lymphomas in patients with and without human immunodeficiency virus. Cancer, 73, 2570-2582.
4. Eby, N. L., Grufferman, S., Flannelly, C. M., Schold, S. C., Vogel, F. S. and Burger, P. C. (1988). Increasing incidence of primary brain lymphoma in the US. Cancer, 62, 2461-2465.
5. Krogh-Jensen, M., d'Amore, F., Jensen, M. K., Christensen, B. E., Thorling, K., Pedersen, M., Johansen, P., Boesen, A. M. and Andersen, E. (1995). Clinicopathologic features, survival and prognostic factors of primary central nervous system lymphomas: Trends in incidence of primary central nervous system lymphomas and primary malignant tumors in a well-defined geographical area. Leuk. Lymphoma, 19, 223-233.
6. Bessel, E. M., Graus, F., Punt, J A. G., Firth, J. L., Hope, D. T., Moloney, A. J., Lopez-Guillermo, A. and Villa, S. (1996). Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J. Clin. Oncol., 14, 945-954.
7. Pollack, I. F., Lunsford, L. D., Flickinger, J. C. and Dameshek, H. L. (1989). Prognostic factors in the diagnosis and treatment of primary central nervous system lymphomas. Cancer, 63, 939-947.
8. Auperin, I., Mikol, J., Oksenhendler, E., Thiebaut, J. B., Brunet, M., Dupont, B. and Morinet, F. (1994). Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathol. Appl. Neurobiol., 20, 243-252.
9. Chang, K. L., Flaris, N., Hickey, W. F., Johnson, R. M., Meyer, J. S. and Weiss, L. M. (1993). Brain lymphomas of immunocompetent and immunocompromised patients: Study of the association with Epstein-Barr virus. Modern Pathol., 6, 427-432.
10. DeAngelis, L. M, Wong, E., Rosenblum, M. and Furneaux, H. (1992). Epstein-Barr virus in the acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer, 70, 1607-1611.
11. Geddes, J. F., Bhattacharjee, M. B., Savage, K., Scaravilli, F. and McLaughlin, J. E. (1992). Primary cerebral lymphoma: A study of 47 cases probed for Epstein-Barr virus genome. J. Clin. Pathol., 45, 587-590.
12. Hamilton-Dutoit, S. J., Raphael, M., Audouin, J., Diebold, J., Lisse, I., Pedersen, C., Oksenhendler, E., Marelle, L. and Pallesen, G. (1993). In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrom-related lymphomas: Correlation with tumor morphology and primary site. Blood, 82, 619-624.
13. Ironside, J. W. (1992). Epstein-Barr virus gene expression in CNS lymphomas. Clin. Neuropathol., 11, 210 (abstr).
14. Murphy, J. K., Young, L. S., Bevan, I. S., Lewis, F. A., Dockey, D., Ironside, J. W., O'Brien, C. J. and Wells, M. (1990). Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue. J. Clin. Pathol., 43, 220-223.
15. Rouah, E., Rogers, B. B., Wilson, D. R., Kirkpatrick, J. B. and Buffone, G. J. (1990). Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction and in situ hybridization. Hum. Pathol., 21, 545-550.
16. d'Amore, F., Christensen, B. E., Brincker, H., Pedersen, N. T., Thorling, K., Hastrup, J., Pedersen, M., Jensen, M. K., Johansen, P., Andersen, E., Bach, B. and Sørensen, E. (1991). Clincopathologic features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur. J. Cancer, 27, 1201-1208.
17. d'Amore, F., Johansen, P., Houmand, A., Weisenburger, D. D. and Mortensen, L. S. (1996). Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: Highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood, 87, 1045-1055.
18. Glickman, J. N., Howe, J. G. and Steitz, J. A. (1988). Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol., 62, 902-911.
19. Gilligan, K., Rajadurai, P., Resnick, L. and Raab-Traub, N. (1990). Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS associated leucoplakia. Proc: Natl. Acad. Sci. USA., 87, 8790-8794.
20. Knutson, G. and Spaulding, D. (1995). β-actin as a positive control for detection of mRNA by in situ hybridization (ISH). Modern Pathol., 8, 166A.
21. Craig, F. E., Gulley, M. L. and Banks, P. M. (1993). Posttransplantation lymphoproliferative disorders. Am. J. Clin. Pathol., 99, 265-276.
22. Karp, J. E. and Broder, S. (1992). The pathogenesis of AIDS lymphoma: a foundation for addressing the challenges of therapy and prevention. Leuk. Lymphoma, 8, 167-188.
23. Sander, C. A., Medeiros, L. J., Weiss, L. M., Yano, T., Sneller, M. C. and Jaffe, E. S. (1992). Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am. J. Surg. Pathol., 16, 1170-1182.
24. Weiss, L. M., Jaffe, E., Liu, X-F., Chen, Y-Y., Shibata, D. and Medeiros, L. J. (1992). Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy-like lymphoma. Blood, 79, 1789-1795.
25. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G. and Wiman, K. G. (1993). EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA, 90, 5455-5459.
26. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E. and Rickinson, A. (1991). Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell, 65, 1107-1115.
27. Shiramizu, B., Barriga, F., Neequaye, J., Jafri, A., Della-Favera, R., Neri, A., Guttierez, M., Levine, P. and Magrath, I. (1991). Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood, 77, 1516-1526.
28. Gilligan, K., Rajadurai, P., Resnick, L. and Raab-Traub, N. (1990). Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA, 87, 8790-8794.
29. Niedobitek, G., Herbst, H., Young, L. S., Brooks, L., Masucci, M. G., Crocker, J., Rickinson, A. B. and Stein, H. (1992). Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood, 79, 2520-2526.
30. Harris, C. C. and Hollstein, M. (1993). Clinical implications of the p53 tumor-suppressor gene. N. Eng. J. Med., 329, 1318-1327.
31. Piris, M. A., Villuendas, R. and Martinez, J. C. (1995). p53 expression in non-Hodgkin's lymphomas: A marker of p53 inactivation? Leuk. Lymphoma, 17, 35-42.
32. Orazi, A., Cattoretti, G., Heerema, N. A., Sozzi, G., John, K. and Neiman, R. S. (1993). Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: An immunohistochemical study of bone marrow biopsies. Modern Pathol., 6, 521-525.
33. Rouby, S. E., Thomas, A., Costin, D., Rosenberg, C. R., Potmesil, M., Silber, R. and Newcomb, E. W. (1993). p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood, 82, 3452-3459.
34. Pins, M. A., Pezella, F. and Martinez-Montero, J. C. (1994). p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br. J. Cancer, 69, 337-341.
35. Korkolopoulou, P., Oates, J., Kittas, C. and Crocker, J. (1994). p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphoma. J. Clin. Pathol., 47, 9-14.
36. Soini, Y., Pääkkö, P., Alavaikko, M. and Vähäkangas, M. (1992). p53 expression in lymphatic malignancies. J. Clin. Pathol., 45, 1011-1014.
37. Kramer, M. H. H., Hermans, J., Parker, J., Krol, A. D. G., Kluin-Nelemans, J. C., Haak, H. L., van Groningen, K., van Krieken, J. H. J. M., de Jong, D. and Kluin, P. M. (1996). Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study. J. Clin. Oncol., 14, 2131-2138.
38. Wilson, W. H., Teruya-Feldstein, J., Fest, T., Harris, C., Steinberg, S. M., Jaffe, E. S. and Raffeld, M. (1997). Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood, 89, 601-609.
39. Hockenbery, D. M. (1992). The bcl-2 oncogene and apoptosis. Semin. Immunol., 4, 413-420.
40. Gulley, M. L., Dent, G. A. and Ross, D. W. (1992). Classification and staging of lymphoma by molecular genetics. Cancer, 69, 1600-1606.
41. Camilleri-Broët, S., Davi, F., Feuillard, J. Bourgeois, C., Seilhean, D., Hauw, J-J. and Raphaël, M. (1995). High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood, 86, 432-435.
42. Hermine, O., Haioun, C., Lepage, E., d'Agay, M. F., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J. P., Diebold, J., Reyas, F. and Gaulard, P. (1996). Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphomas. Blood, 87, 265-272.
43. Tang, S. C., Visser, L., Hepperle, B., Hanson, J. and Poppema, S. (1994). Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large cell non-Hodgkin's lymphomas: An analysis of 83 cases. J. Clin. Oncol., 12, 149-154.
44. Hall, P. A., Richards, M. A., Gregory, W. M., d'Ardenne, A. J., Lister, T. A. and Stansfeld, A. G. (1988). The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J. Pathol., 154, 223-235.